Lymphotoxin beta Receptor Monoclonal Antibody (eBio3C8 (3C8)), Functional Grade, eBioscience

Life Technologies Corporation has been awarded contract A207_PO-0473849 by the University of Virginia, effective August 27, 2026. The cumulative contract value totals $2,542.65. While the specific products and services are not detailed in the award documentation provided, Life Technologies Corporation specializes in life sciences research tools, reagents, and instrumentation, suggesting the procurement likely involves laboratory supplies or analytical equipment supporting the University of Virginia's research operations.

The contract represents a purchase order arrangement within Virginia's state procurement system. Without additional documentation specifying the statement of work, period of performance, or detailed line items, the exact scope of delivery cannot be definitively established from the information provided. Further procurement records or purchase order documentation would be necessary to delineate the specific products delivered, performance locations, contract duration, and any milestone or payment schedules associated with this award.